Press release
Follicular Lymphoma Market to Grow Substantially by 2032 - Asserts DelveInsight |Key Companies - Epizyme, Merck, Genentech, Incyte, Syndax, Xynomic, Janssen, XEME Biopharma, Nordic Nanovector, BeiGene, MEI Pharma, and TCR2 Therapeutics
Follicular Lymphoma Market
The Follicular Lymphoma market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Follicular Lymphoma: An Overview
Follicular Lymphoma (FL) is a slow-growing and indolent form of non-Hodgkin lymphoma (NHL) that arises from B-lymphocytes. As per the Leukemia & Lymphoma Society, "Non-Hodgkin Lymphoma (NHL) is a type of cancer that generally develops in the lymph nodes and lymphatic tissue found in organs such as the stomach, and intestines, or skin. In some cases, the NHL involves bone marrow and blood."
Follicular Lymphoma accounts for 20-30% of all NHL cases. It is usually a slow-growing (indolent) lymphoma, although some FL can grow rapidly.
Follicular Lymphoma Market Key Facts
It is observed that Follicular Lymphoma accounts for 20-30% of NHL.
The average age of diagnosis of Follicular Lymphoma is 60-65 years and is rare in young people.
As per the study conducted by Smith et al. (2015), the incidence of Follicular Lymphoma was 3.23 per 100,000.
Follicular Lymphoma treatment includes chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. Patients with early-stage FL (Ann Arbor stages I or II) may be treated with radiation therapy alone or with radiation plus chemotherapy.
Find a sample copy of the Follicular Lymphoma Market report at:
https://www.delveinsight.com/sample-request/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Follicular Lymphoma Market
As per DelveInsight, the Follicular Lymphoma Market Size is expected to increase during the forecast period owing to the increasing incidence of Follicular Lymphoma and the expected launch of emerging therapies.
The market outlook section of the report helps to build a detailed comprehension of the historical, current & forecasted Follicular Lymphoma market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Follicular Lymphoma market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Follicular Lymphoma Epidemiology
The epidemiology section covers detailed insights into the historical and current Follicular Lymphoma patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.
Follicular Lymphoma Epidemiology Segmentation
Total Incident Cases of Follicular Lymphoma
Mutation-specific Incident Cases of Follicular Lymphoma
Risk-specific Incident Cases of Follicular Lymphoma
Refractory/Relapsed Incident Cases of Follicular Lymphoma
Stage-specific Incident Cases of Follicular Lymphoma
Treatable Cases of Follicular Lymphoma
Explore more about Follicular Lymphoma Epidemiology @
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Follicular Lymphoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Follicular Lymphoma market or expected to get launched in the market during the study period. The analysis covers Follicular Lymphoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Follicular Lymphoma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for a sample report to understand more about the Follicular Lymphoma pipeline development activities @ https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Follicular Lymphoma Therapeutics Assessment
The treatment of Follicular Lymphoma is based on the severity of associated symptoms and the rate of cancer growth. Currently, there are approx. 50+ key companies which are developing therapies for Follicular Lymphoma. Several of the Follicular Lymphoma drug candidates are in the most advanced stage, i.e. phase III and few of the therapies are expected to hit the market in the coming years.
Some of the prominent companies in the Follicular Lymphoma Therapeutics Market include Epizyme, Merck & Co, Genentech, Incyte Corporation, Syndax Pharmaceuticals, Dr Reddy's Laboratories, Novartis, ADC Therapeutics, Xynomic Pharmaceuticals, Cho Pharma Inc., Janssen, XEME Biopharma Inc., Shanghai Yingli Pharmaceutical, Novartis, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Beijing Mabworks Biotech Co., Ltd., Archigen Biotech, Hutchison Medipharma Limited, Nordic Nanovector, TG Therapeutics, BeiGene, Allogene Therapeutics, MEI Pharma, Inc., Pfizer, Innovent Biologics (Suzhou) Co. Ltd., Enterome, AstraZeneca, Nanjing Sanhome Pharmaceutical, Co., Ltd., Takeda, Bristol-Myers Squibb, TCR2 Therapeutics, and several other.
Some of the key therapies in the Follicular Lymphoma Therapeutics Landscape include Mosunetuzumab, Tafasitamab, Tazverik (Tazemetostat), Pembrolizumab, Zanubrutinib, Abexinostat, ME-401, Tisagenlecleucel, Parsaclisi (IBI376), and Others.
Learn more about the emerging therapies & key companies in the Follicular Lymphoma Therapeutics Market @ https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Follicular Lymphoma Competitive Intelligence Analysis
4. Follicular Lymphoma Market Overview at a Glance
5. Follicular Lymphoma Disease Background and Overview
6. Follicular Lymphoma Patient Journey
7. Follicular Lymphoma Epidemiology and Patient Population
8. Follicular Lymphoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Follicular Lymphoma Unmet Needs
10. Key Endpoints of Follicular Lymphoma Treatment
11. Follicular Lymphoma Marketed Products
12. Follicular Lymphoma Emerging Therapies
13. Follicular Lymphoma Seven Major Market Analysis
14. Attribute Analysis
15. Follicular Lymphoma Market Outlook (7 major markets)
16. Follicular Lymphoma Access and Reimbursement Overview
17. KOL Views on the Follicular Lymphoma Market.
18. Follicular Lymphoma Market Drivers
19. Follicular Lymphoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Get the Detailed TOC of the Follicular Lymphoma Market report here:
https://www.delveinsight.com/sample-request/follicular-lymphoma-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Follicular Lymphoma Market to Grow Substantially by 2032 - Asserts DelveInsight |Key Companies - Epizyme, Merck, Genentech, Incyte, Syndax, Xynomic, Janssen, XEME Biopharma, Nordic Nanovector, BeiGene, MEI Pharma, and TCR2 Therapeutics here
News-ID: 2613062 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Lymphoma
Lymphoma Treatment Market - Liberating Lives from Lymphoma: State-of-the-Art Tre …
Newark, New Castle, USA: The "Lymphoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lymphoma Treatment Market: https://www.growthplusreports.com/report/lymphoma-treatment-market/8879
This latest report researches the industry structure, sales, revenue,…
Lymphoma Treatment Market - Inspiring Resilience, Shaping Survival: Innovations …
Newark, New Castle, USA - new report, titled Lymphoma Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Lymphoma Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Lymphoma Treatment market. The report offers an overview of the market, which…
Lymphoma Therapeutics Market: New Frontiers in Lymphoma Therapeutics | By AMR
Allied Market Research recently said Lymphoma is a type of cancer that affects the lymphatic system, which is an integral part of the body's immune system. While chemotherapy and radiation therapy have been the standard treatment options for lymphoma, recent advances in research have led to the development of new targeted therapies and immunotherapies.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-toc-and-sample/1448
One such targeted therapy is monoclonal antibodies, which can specifically target…
Daratumumab Market Precise Analysis , Forecast || key Players- Multiple Myeloma, …
Looking at the current market trends as well as the promising demand status of the “Daratumumab Market”, it can be projected that the future years will bring out positive outcomes. This research report added by Market Research Hub (MRH) on its online portal delivers clear insight about the changing tendencies across the global market. Readers can gather prime facets connected to the target market which includes product, end-use and application;…
T Cell Lymphoma Market T Cell Lymphoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. T-Cell Lymphoma Market Analysis
2. Mechanism of T-Cell Lymphoma Therapeutics
3. T-Cell Lymphoma Drug Market Overview
3.1 Current Market Scenario
3.2 T Cell Lymphoma Clinical Pipeline Overview
4. T-Cell Lymphoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. T-Cell Lymphoma Drug Market Future Prospects
6. T-Cell Lymphoma Drug Clinical Pipeline By Company…
B Cell Lymphoma Market B Cell Lymphoma Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to B Cell Lymphoma
1.1 Outline
1.1.1 Non-Hodgkin’s Lymphoma
1.1.2 Hodgkin’s Lymphoma
1.2 Classification of the B Cell lymphoma
1.2.1 Diffuse Large B Cell Lymphoma
1.2.2 Follicular Lymphoma
1.2.3 Mantle Cell Lymphoma
1.2.4 Burkitt Lymphoma
1.3 Stages of…
